Plain-English translation of NCT04732910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Cystic Fibrosis research guide →This study is checking how well CFTR-modulator medications work in people with cystic fibrosis by measuring specific markers in the body. Researchers will look at how the medication affects your lungs, airways, and other systems using special tests and measurements. The goal is to understand whether the treatment is helping your body manage cystic fibrosis more effectively.
Currently, doctors don't have a clear, standardized way to measure whether this medication is actually working in each patient's body. This study is trying to develop better tools to track how well the treatment is helping, which could improve how doctors adjust care in the future.
You likely qualify if…
You likely don't qualify if…
You would visit the study center before you start the medication and then return at 12 weeks and 52 weeks after starting treatment. At each visit, researchers will perform several non-invasive tests to measure how your body is responding—such as measuring salt levels in your sweat, checking airway function, and possibly doing lung imaging. You'll also provide airway samples and have measurements of your lung function and overall health tracked.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Germany